GLOW Protocol (BPC-157 / GHK-CU / TB-500) – 70mg

The GLOW Protocol is a triple peptide blend combining BPC-157, GHK-Cu, and TB-500 into a single 70mg lyophilized vial delivering the same three compound regenerative research foundation as the F40 Biotech Glow Pen 130mg in a reconstitute vial format. Hudson Science’s lyophilized vial presentation provides precise dosing flexibility and reconstitution concentration control for researchers who require adjustable dosing capability or in vitro application suitability that prefilled pen systems cannot accommodate.

Each of the three peptide components contributes a distinct and complementary mechanism to the blend’s overall research profile. BPC-157 (Body Protection Compound 157) promotes angiogenesis through nitric oxide pathway modulation, upregulates growth hormone receptors in injured tissue, and activates the FAK paxillin pathway driving cell migration and wound healing. It provides vascular development and growth factor signaling foundation across tendon, ligament, muscle, gut, and neural tissue research contexts. TB-500 (Thymosin Beta-4) operates through LKKTETQ actin binding domain mediated upregulation of actin polymerization and cell motility pathways. Enhancing cellular migration to injury sites and supporting new blood vessel formation through a complementary angiogenic mechanism that pairs synergistically with BPC-157’s nitric oxide pathway activity. GHK-Cu (Copper Tripeptide-1) contributes extracellular matrix remodeling through metalloproteinase modulation and collagen and elastin synthesis stimulation. Addressing the structural tissue rebuilding phase of repair that follows the vascular and cellular processes the other two compounds support, with its copper chelation providing additional antioxidant and matrix regulatory activity beyond the peptide sequence itself.

The GLOW Protocol lyophilized vial and the F40 Biotech Glow Pen serve the same three compound research profile across different administration format preferences, the vial offering reconstitution flexibility, precise concentration adjustment, and in vitro research applicability, the pen offering ready to use fixed dose convenience for repeated parenteral administration. CSD stocking both formats from different manufacturers gives researchers complete format flexibility within the same compound combination. Individual components are also available separately across multiple formats and concentrations throughout CSD’s full peptide range for researchers requiring custom dosing ratios or single compound sourcing.

Hudson Science formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity across all three components before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and Hudson Science’s GLOW Protocol meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched in tissue repair, regenerative, and skin biology research contexts. Browse CSD’s full peptide range for complete sourcing.